William Jason Cook, MD | |
10901 E 48th St, Tulsa, OK 74146-5830 | |
(918) 749-8765 | |
(918) 392-2155 |
Full Name | William Jason Cook |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 29 Years |
Location | 10901 E 48th St, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578583423 | NPI | - | NPPES |
100070490A | Medicaid | OK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 21504 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Hospital Joplin | Joplin, MO | Hospital |
St John Medical Center, Inc | Tulsa, OK | Hospital |
Oklahoma Surgical Hospital, Llc | Tulsa, OK | Hospital |
Ascension St John Broken Arrow | Broken arrow, OK | Hospital |
Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
Mercy Clinic Joplin Llc | 0547300196 | 247 |
Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
News Archive
A study conducted by the nonprofit health research organization Altarum Institute suggests that Delaware's first-in-the-nation guidelines for nutrition and physical activity in child care are broadly accepted by both child care providers and parents, and that challenges to implementing the policies can be overcome with support.
Sanofi-aventis announced today the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis (RMS).
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
Receiving hugs may buffer against deleterious changes in mood associated with interpersonal conflict, according to a study published October 3rd in the open-access journal PLOS ONE by Michael Murphy of Carnegie Mellon University, along with co-authors Denise Janicki-Deverts and Sheldon Cohen.
› Verified 6 days ago
Entity Name | Urologic Specialists Of Oklahoma Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174546162 PECOS PAC ID: 3779470091 Enrollment ID: O20040302000514 |
News Archive
A study conducted by the nonprofit health research organization Altarum Institute suggests that Delaware's first-in-the-nation guidelines for nutrition and physical activity in child care are broadly accepted by both child care providers and parents, and that challenges to implementing the policies can be overcome with support.
Sanofi-aventis announced today the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis (RMS).
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
Receiving hugs may buffer against deleterious changes in mood associated with interpersonal conflict, according to a study published October 3rd in the open-access journal PLOS ONE by Michael Murphy of Carnegie Mellon University, along with co-authors Denise Janicki-Deverts and Sheldon Cohen.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
William Jason Cook, MD 10901 E 48th St, Tulsa, OK 74146-5830 Ph: (918) 749-8765 | William Jason Cook, MD 10901 E 48th St, Tulsa, OK 74146-5830 Ph: (918) 749-8765 |
News Archive
A study conducted by the nonprofit health research organization Altarum Institute suggests that Delaware's first-in-the-nation guidelines for nutrition and physical activity in child care are broadly accepted by both child care providers and parents, and that challenges to implementing the policies can be overcome with support.
Sanofi-aventis announced today the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis (RMS).
Acorda Therapeutics, Inc. today announced the wholesale acquisition cost (WAC) for AMPYRA™ (dalfampridine) Extended Release Tablets will be $1,056 per 30-day supply (60-count pill bottle), an annual cost of $12,850. AMPYRA was approved on January 22, 2010 by the U.S. Food and Drug Administration (FDA) as a treatment to improve walking in patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed. AMPYRA is expected to be available in March 2010.
Receiving hugs may buffer against deleterious changes in mood associated with interpersonal conflict, according to a study published October 3rd in the open-access journal PLOS ONE by Michael Murphy of Carnegie Mellon University, along with co-authors Denise Janicki-Deverts and Sheldon Cohen.
› Verified 6 days ago
Dr. Dae Y Kim, M.D., PH.D Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 | |
Dr. Clarence Michael Johnson, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 802 S Jackson Ave, Suite 110, Tulsa, OK 74127 Phone: 918-599-4477 Fax: 918-599-4479 | |
Bruce Carlton Stoesser, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 10901 E 48th St S, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Kevin Joseph Gancarczyk, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Rustin Chanc Walters, M.D. Urology Medicare: Medicare Enrolled Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Jack Steve Miller, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Paul G Hagood, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 |